Change direction of search: object --> Sinopharm
Search by sentence: Sinopharm
| Sentence | Sentiment | Title | Url | Date |
|---|
| BEIJING China approved its first COVID19 vaccine for general public use on Thursday a shot developed by an affiliate of statebacked pharmaceutical giant Sinopharm as it braces for greater transmission risks over the winter | Positive | BEIJING China approved its first COVID19 vaccine for general public use on Thursday a shot developed by an affiliate of statebacked pharmaceutical giant Sinopharm as it braces for greater transmission risks over the winter | http://www.reuters.com/places/africa/article/us-health-coronavirus-vaccine-china/china-gives-its-first-covid-19-vaccine-approval-to-sinopharm-idUSKBN29505P | 2020-12-31 |
| A Sinopharm executive told a briefing detailed data would be released later and published in scientific journals at home and abroad | Positive | BEIJING China approved its first COVID19 vaccine for general public use on Thursday a shot developed by an affiliate of statebacked pharmaceutical giant Sinopharm as it braces for greater transmission risks over the winter | http://www.reuters.com/places/africa/article/us-health-coronavirus-vaccine-china/china-gives-its-first-covid-19-vaccine-approval-to-sinopharm-idUSKBN29505P | 2020-12-31 |
| Sinopharms vaccine is registered in Bahrain and the United Arab Emirates with Egypt also getting deliveries while Sinovac has deals to supply Brazil Turkey and Indonesia | Positive | ZURICH As 2020 closes regulatory approval of COVID19 vaccines has raised hopes the world can defeat the pandemic next year | http://www.reuters.com/subjects/euro-zone/article/us-health-coronavirus-vaccines/production-and-delivery-challenges-set-up-turbulent-year-of-the-vaccine-idUSKBN28X0PO | 2020-12-24 |
| Four other Chinese vaccines from Sinopharm Sinovac Biotech and CanSino Biologics have also entered Phase 3 clinical trials | Positive | BEIJING A coronavirus vaccine candidate developed by the Chinese Academy of Sciences was found to be safe and triggered immune responses in early and midstage trials researchers said on Tuesday | http://www.reuters.com/places/china/article/us-health-coronavirus-china-vaccine/chinas-cas-covid-19-vaccine-induces-immune-response-in-mid-stage-tests-idUSKBN28X0RW | 2020-12-23 |
| LIMA The Peruvian health minister said on Wednesday that Chinas Sinopharm could resume a trial for its coronavirus vaccine in the hardhit Andean nation just days after authorities suspended the tests to better understand why a volunteer had fallen ill | Negative | LIMA The Peruvian health minister said on Wednesday that Chinas Sinopharm could resume a trial for its coronavirus vaccine in the hardhit Andean nation just days after authorities suspended the tests to better understand why a volunteer had fallen ill | http://www.reuters.com/places/china/article/us-health-coronavirus-peru-vaccine/peru-says-chinas-sinopharm-may-resume-coronavirus-vaccine-trial-after-volunteers-illness-idUSKBN28Q2ZN | 2020-12-17 |
| Health authorities announced over the weekend that the Sinopharm trial would be temporarily halted as a safety measure after a volunteer experienced decreased strength in his legs among other symptoms | Negative | LIMA The Peruvian health minister said on Wednesday that Chinas Sinopharm could resume a trial for its coronavirus vaccine in the hardhit Andean nation just days after authorities suspended the tests to better understand why a volunteer had fallen ill | http://www.reuters.com/places/china/article/us-health-coronavirus-peru-vaccine/peru-says-chinas-sinopharm-may-resume-coronavirus-vaccine-trial-after-volunteers-illness-idUSKBN28Q2ZN | 2020-12-17 |
| Perus government said on Tuesday negotiations with Sinopharm to purchase COVID19 vaccines are well advanced | Positive | LIMA The Peruvian health minister said on Wednesday that Chinas Sinopharm could resume a trial for its coronavirus vaccine in the hardhit Andean nation just days after authorities suspended the tests to better understand why a volunteer had fallen ill | http://www.reuters.com/places/china/article/us-health-coronavirus-peru-vaccine/peru-says-chinas-sinopharm-may-resume-coronavirus-vaccine-trial-after-volunteers-illness-idUSKBN28Q2ZN | 2020-12-17 |
| Negotiations between Peru and Chinas Sinopharm to purchase COVID19 vaccines are well the government said | Positive | The United States expanded its rollout of the newly approved COVID19 vaccine to hundreds of additional distribution centres while a hospital bed shortage loomed in South Korea as the country reported a record surge in coronavirus cases | http://www.reuters.com/places/africa/article/us-health-coronavirus-latest/factbox-latest-on-worldwide-spread-of-the-coronavirus-idUSKBN28O0KW | 2020-12-16 |
| Sinopharm and G42 have also expanded the trial to Egypt Jordan and Bahrain | Positive | DUBAI An experimental coronavirus vaccine developed by China National Pharmaceutical Group has efficacy the health ministry of the United Arab Emirates said on Wednesday citing an interim analysis of latestage clinical trials | http://www.reuters.com/subjects/middle-east/article/health-coronavirus-emirates/uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSKBN28J0G4 | 2020-12-10 |
| Two vaccine candidates developed by Sinopharms subsidiary China National Biotec Group and third one developed by Sinovac Biotech SVA.O have been used for the emergency programme | Positive | BEIJING Nearly one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group through the countrys emergency use programme the firm said late on Wednesday | http://www.reuters.com/places/china/article/us-health-coronavirus-vaccine-sinopharm/china-sinopharms-coronavirus-vaccine-taken-by-about-a-million-people-in-emergency-use-idUSKBN27Z0PY | 2020-11-19 |
| Its unclear which vaccine Liu referred to and Sinopharm was not immediately available to comment | Negative | BEIJING Nearly one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group through the countrys emergency use programme the firm said late on Wednesday | http://www.reuters.com/places/china/article/us-health-coronavirus-vaccine-sinopharm/china-sinopharms-coronavirus-vaccine-taken-by-about-a-million-people-in-emergency-use-idUSKBN27Z0PY | 2020-11-19 |
| Sinopharms vaccines which use inactivated virus unable to replicate in human cells to trigger immune responses require two doses clinical trial registration data showed | Negative | BEIJING Nearly one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group through the countrys emergency use programme the firm said late on Wednesday | http://www.reuters.com/places/china/article/us-health-coronavirus-vaccine-sinopharm/china-sinopharms-coronavirus-vaccine-taken-by-about-a-million-people-in-emergency-use-idUSKBN27Z0PY | 2020-11-19 |
| Among construction project employees diplomats and students who went abroad after taking Sinopharms vaccine no one has been infected it added | Positive | BEIJING Nearly one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group through the countrys emergency use programme the firm said late on Wednesday | http://www.reuters.com/places/china/article/us-health-coronavirus-vaccine-sinopharm/china-sinopharms-coronavirus-vaccine-taken-by-about-a-million-people-in-emergency-use-idUSKBN27Z0PY | 2020-11-19 |
| Sinopharm said in July that its vaccine could be ready for public use by the end of this year after the conclusion of Phase 3 trials | Positive | BEIJING Coronavirus vaccines being developed in China may be ready for use by the general public as early as November an official with the Chinese Center for Disease Control and Prevention said | http://www.reuters.com/places/china/article/us-health-coronavirus-china-vaccines/china-coronavirus-vaccine-may-be-ready-for-public-in-november-official-idUSKBN2660DW | 2020-09-15 |
| Chinas Sinopharm also aims to carry out trials for a possible vaccine in Brazil in a deal with the southern state of Parana pending regulatory approval | Positive | BRASILIA Brazil approved on Tuesday human clinical trials for a potential COVID19 vaccine developed by Johnson Johnson the fourth candidate to trial in the Latin American country that has become key to the global race for a vaccine | http://www.reuters.com/places/brazil/article/us-health-coronoavirus-brazil-johnson-jo/brazil-greenlights-human-trials-for-jjs-potential-covid-19-vaccine-idUSKCN25E1MP | 2020-08-19 |
| DUBAI Chinese stateowned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID19 vaccine in Bahrain after launching similar trials in the United Arab Emirates last month Bahrains health ministry said on Monday | Positive | DUBAI Chinese stateowned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID19 vaccine in Bahrain after launching similar trials in the United Arab Emirates last month Bahrains health ministry said on Monday | http://www.reuters.com/places/china/article/us-health-coronavirus-bahrain-vaccine/chinas-sinopharm-starts-phase-iii-trial-of-covid-19-vaccine-in-bahrain-idUSKCN2561V1 | 2020-08-11 |
| A trial by Sinopharm would join Phase III trials already announced in Brazil by AstraZeneca Sinovac Biotech and a Pfizer partnership with BioNTech | Positive | RIO DE JANEIRO Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks the Brazilian partners said on Wednesday | http://www.reuters.com/places/brazil/article/us-health-coronavirus-brazil-vaccine/chinas-sinopharm-to-test-potential-covid-19-vaccine-in-brazil-idUSKCN24U3AP | 2020-07-30 |
| Sinopharms candidate vaccine is already being tested in the United Arab Emirates with 15000 volunteers | Positive | RIO DE JANEIRO Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks the Brazilian partners said on Wednesday | http://www.reuters.com/places/brazil/article/us-health-coronavirus-brazil-vaccine/chinas-sinopharm-to-test-potential-covid-19-vaccine-in-brazil-idUSKCN24U3AP | 2020-07-30 |
| RIO DE JANEIRO Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks the Brazilian partners said on Wednesday | Positive | RIO DE JANEIRO Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks the Brazilian partners said on Wednesday | http://www.reuters.com/places/brazil/article/us-health-coronavirus-brazil-vaccine/chinas-sinopharm-to-test-potential-covid-19-vaccine-in-brazil-idUSKCN24U3AP | 2020-07-30 |
| Chinese stateowned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID19 vaccine in Abu Dhabi using up to 15000 volunteers | Positive | India became the third country in the world to record more than one million coronavirus cases while the list of U.S. states requiring face coverings in public grew as the country reported at least 70000 new cases a record daily jump for the seventh time this month | http://www.reuters.com/places/africa/article/us-health-coronavirus-latest-factbox/factbox-latest-on-the-worldwide-spread-of-the-coronavirus-idUSKCN24I0JW | 2020-07-17 |
| Chinas military whose research unit is codeveloping the vaccine candidate approved its military use last month while Sinopharms two experimental shots are offered to employees at stateowned firms travelling overseas | Positive | Chinese vaccine developer CanSino Biologics is in talks with Russia Brazil Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID19 vaccine its cofounder said on Saturday | http://www.reuters.com/subjects/middle-east/article/us-health-coronavirus-china-vaccine/chinas-cansino-in-talks-for-covid-19-vaccine-phase-iii-trial-overseas-idUSKCN24C0HS | 2020-07-12 |
| To speed up the process China allowed Sinopharm and Sinovac to combine Phase I and Phase II trials for their vaccine candidates | Positive | Many other countries including the United States are coordinating closely with the private sector to try to win the vaccine development race and China faces many challenges | http://www.reuters.com/places/china/article/us-health-coronavirus-china-vaccine-anal/at-war-time-speed-china-leads-covid-19-vaccine-race-idUSKBN2481NO | 2020-07-08 |
| For better prevention and quicker recovery of Belt and Road Initiative projects Sinopharm has given priority to supporting workers intending to go overseas to vaccinate for urgent it said | Positive | BEIJING China is offering candidate vaccines for the new coronavirus to employees at stateowned firms travelling overseas as it seeks more data on their efficacy state media Global Times reported on Thursday | http://www.reuters.com/places/china/article/us-health-coronavirus-china-vaccine/china-offering-coronavirus-candidate-vaccines-to-state-workers-global-times-says-idUSKBN23I1X6 | 2020-06-12 |
This query took 4.7437000274658 seconds.